Literature DB >> 18363553

Neuropilins: structure, function and role in disease.

Caroline Pellet-Many1, Paul Frankel, Haiyan Jia, Ian Zachary.   

Abstract

NRPs (neuropilins) are co-receptors for class 3 semaphorins, polypeptides with key roles in axonal guidance, and for members of the VEGF (vascular endothelial growth factor) family of angiogenic cytokines. They lack a defined signalling role, but are thought to mediate functional responses as a result of complex formation with other receptors, such as plexins in the case of semaphorins and VEGF receptors (e.g. VEGFR2). Mutant mouse studies show that NRP1 is essential for neuronal and cardiovascular development, whereas NRP2 has a more restricted role in neuronal patterning and lymphangiogenesis, but recent findings indicate that NRPs may have additional biological roles in other physiological and disease-related settings. In particular, NRPs are highly expressed in diverse tumour cell lines and human neoplasms and have been implicated in tumour growth and vascularization in vivo. However, despite the wealth of information regarding the probable biological roles of these molecules, many aspects of the regulation of cellular function via NRPs remain uncertain, and little is known concerning the molecular mechanisms through which NRPs mediate the functions of their various ligands in different cell types.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363553     DOI: 10.1042/BJ20071639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  142 in total

Review 1.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

2.  Differential expression of neuronal genes in Müller glia in two- and three-dimensional cultures.

Authors:  M Joseph Phillips; Deborah C Otteson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.

Authors:  Jiasheng Zhang; Mahmoud Razavian; Sina Tavakoli; Lei Nie; George Tellides; Joseph M Backer; Marina V Backer; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

4.  Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1.

Authors:  Heli Liu; Z Sean Juo; Ann Hye-Ryong Shim; Pamela J Focia; Xiaoyan Chen; K Christopher Garcia; Xiaolin He
Journal:  Cell       Date:  2010-08-19       Impact factor: 41.582

5.  Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Authors:  Matthew W Parker; Ping Xu; Xiaobo Li; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 6.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

7.  VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.

Authors:  Vedanta Mehta; Laura Fields; Ian M Evans; Maiko Yamaji; Caroline Pellet-Many; Timothy Jones; Marwa Mahmoud; Ian Zachary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

8.  Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies.

Authors:  Elizabeth Goldmuntz; Prasuna Paluru; Joseph Glessner; Hakon Hakonarson; Jaclyn A Biegel; Peter S White; Xiaowu Gai; Tamim H Shaikh
Journal:  Congenit Heart Dis       Date:  2011-10-20       Impact factor: 2.007

9.  Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.

Authors:  Ricardo Saban; Marcia R Saban; Julie Maier; Ben Fowler; Mark Tengowski; Carole A Davis; Xue-Ru Wu; Daniel J Culkin; Paul Hauser; Joseph Backer; Robert E Hurst
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

10.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.